PATENT CLAIM ANALYSIS

Application Number: 15893925
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "008200"]

Abstract:
Methods and compositions for modulating blood-neural barrier (BNB) for the treatment of CNS conditions such as edema, and for increased drug delivery efficacy across the BNB. The present invention further relates to improved tPA treatment of ischemic cerebrovascular and related diseases in combination with antagonism of the PDGF signaling pathway. The inventive method and composition is particularly suitable for conjunctive therapy of ischemic stroke using tPA and an anti-PDGF-C antagonist or an anti-PDGFR-α antagonist.

Claim (Index 60):
The method of  claim 59  wherein the animal is a mammal.

Metadata:
- Claim Count in Document: 164.0
- Percentile: 88.0
- Lexical Diversity: 1.35593
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15286818', '14282808', '13407270', '11736499', '11718786']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8124378064194122
- 35 USC 102 Novelty (BERT): 0.5832197777318775
- Combined Prediction Score: 0.7895160035506588
- Mean Citation Score: 469.83596000000006
- Max Citation Score: 521.90796
- Similarity Product: 375.7345498773194

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test